1320 nm Nd:YAG Laser for Improving the Appearance of Onychomycosis
A Randomized, Placebo-Controlled Study of the 1320 nm Nd:YAG Laser for Improving the Appearance of Onychomycosis
1 other identifier
interventional
10
1 country
1
Brief Summary
The purpose of this clinical study is to improve the appearance of onychomycosis and morphology of the nail (fungal infection). The researcher can use a light based therapy to gently heat the toenail infected with fungus to improve the appearance of onychomycosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Dec 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 20, 2011
CompletedFirst Posted
Study publicly available on registry
December 23, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedNovember 1, 2022
October 1, 2022
1 year
December 20, 2011
October 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improving the Appearance of fungal nail
Laser treatment to Improve the Appearance of Onychomycosis
6 months
Study Arms (1)
Laser treatment
OTHERLaser treatment to Improve the Appearance of Onychomycosis
Interventions
Eligibility Criteria
You may qualify if:
- Adult Male/ female has been diagnose with fungal nail infection on both great toenails.
You may not qualify if:
- Any other toenail disease including, but not limited to psoriasis, lichen planus, pachyonychia congenita, etc. as determined by the investigator.
- Excessively thick or hypertrophic nails.
- Subjects with diabetes.
- Subjects that are pregnant
- Receipt of any topical therapy for onychomycosis (i.e. antifungal) within 2 weeks of enrollment, systemic therapy for onychomycosis (i.e. antifungal) within 3 months of enrollment, or any other procedures done on the test area within 6 months of enrollment.
- Subjects with impaired immune systems including, but not limited to HIV, transplant patients on immunosuppression, etc.
- Current or history of psychiatric disease that would interfere with ability to comply with the study protocol or give informed consent.
- History of alcohol or drug abuse that would interfere with ability to comply with the study protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beckman Laser Institute
Irvine, California, 92612, United States
Related Publications (1)
Ortiz AE, Truong S, Serowka K, Kelly KM. A 1,320-nm Nd: YAG laser for improving the appearance of onychomycosis. Dermatol Surg. 2014 Dec;40(12):1356-60. doi: 10.1097/DSS.0000000000000189.
PMID: 25357174RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristen Kelly, MD
Beckman Laser Institute, UCI
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Kristen Kelly, M.D., Professor Departments of Dermatology and Surgery
Study Record Dates
First Submitted
December 20, 2011
First Posted
December 23, 2011
Study Start
December 1, 2011
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
November 1, 2022
Record last verified: 2022-10